Proteasome: target for acute and chronic GVHD?

Por Magenau, John M., Reddy, Pavan
Publicado em 2014

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives

Por Toubai, Tomomi, Mathewson, Nathan D., Magenau, John, Reddy, Pavan
Publicado no Front Immunol (2016)

The Challenge of t (6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young Adult

Por Song, Yeohan, Bixby, Dale, Roulston, Diane, Magenau, John, Choi, Sung Won
Publicado no J Leuk (Los Angel) (2014)

Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung

Por Abedin, Sameem, Yanik, Gregory A., Braun, Thomas, Pawarode, Attaphol, Magenau, John, Goldstein, Steven C., Levine, John E., Kitko, Carrie L., Couriel, Daniel R.
Publicado no Biol Blood Marrow Transplant (2015)

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Por Choi, Sung Won, Braun, Thomas, Henig, Israel, Gatza, Erin, Magenau, John, Parkin, Brian, Pawarode, Attaphol, Riwes, Mary, Yanik, Greg, Dinarello, Charles A., Reddy, Pavan
Publicado no Blood (2017)

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Por Harris, Andrew C., Kitko, Carrie L., Couriel, Daniel R., Braun, Thomas M., Choi, Sung W., Magenau, John, Mineishi, Shin, Pawarode, Attaphol, Yanik, Gregory, Levine, John E.
Publicado em 2013

A PROGNOSTIC SCORE FOR ACUTE GRAFT-VERSUS-HOST DISEASE BASED ON BIOMARKERS: A MULTICENTER STUDY

Por Levine, John E., Braun, Thomas M., Harris, Andrew C., Holler, Ernst, Taylor, Austin, Miller, Holly, Magenau, John, Weisdorf, Daniel J., Ho, Vincent T., Bolaños-Meade, Javier, Alousi, Amin M., Ferrara, L.M.
Publicado no Lancet Haematol (2015)

Siglec-G represses DAMP-mediated effects on T cells

Por Toubai, Tomomi, Rossi, Corinne, Oravecz-Wilson, Katherine, Zajac, Cynthia, Liu, Chen, Braun, Thomas, Fujiwara, Hideaki, Wu, Julia, Sun, Yaping, Brabbs, Stuart, Tamaki, Hiroya, Magenau, John, Zheng, Pang, Liu, Yang, Reddy, Pavan
Publicado no JCI Insight (2017)

Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial

Por Kitko, Carrie L., Braun, Thomas, Couriel, Daniel R., Choi, Sung W., Connelly, James, Hoffmann, Sandra, Goldstein, Steven, Magenau, John, Pawarode, Attaphol, Reddy, Pavan, Schuler, Charles, Yanik, Greg, Ferrara, James, Levine, John E.
Publicado no Biol Blood Marrow Transplant (2015)

Engraftment Syndrome following allogeneic hematopoietic cell transplantation predicts poor outcomes

Por Chang, Lawrence, Frame, David, Braun, Thomas, Gatza, Erin, Hanauer, David A., Zhao, Shuang, Magenau, John M., Schultz, Kathryn, Tokala, Hemasri, Ferrara, James L.M., Levine, John E., Reddy, Pavan, Paczesny, Sophie, Choi, Sung Won
Publicado em 2014

Infectious Risk Following Allogeneic Hematopoietic Cell Transplant Complicated by Acute Graft-Versus-Host Disease

Por Miller, Holly K., Braun, Thomas M., Stillwell, Terri, Harris, Andrew C., Choi, Sung, Connelly, James, Couriel, Daniel, Goldstein, Steven, Kitko, Carrie L., Magenau, John, Pawarode, Attaphol, Reddy, Pavan, Riwes, Mary, Yanik, Gregory A., Levine, John E.
Publicado no Biol Blood Marrow Transplant (2016)

Frequency of CD4(+)CD25(hi)FOXP3(+) Regulatory T Cells has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host-Disease

Por Magenau, John M, Qin, Xuemei, Tawara, Isao, Rogers, Clare E, Kitko, Carrie, Schlough, Matthew, Bickley, Daniel, Braun, Thomas M, Jang, Pil-Sang, Lowler, Kathleen P, Jones, Dawn M, Choi, Sung W, Reddy, Pavan, Mineishi, Shin, Levine, John E, Ferrara, James LM, Paczesny, Sophie
Publicado em 2010

Etanercept plus topical corticosteroids as initial therapy for grade 1 acute graft-versus-host disease after allogeneic hematopoietic cell transplant

Por Gatza, Erin, Braun, Thomas, Levine, John E., Ferrara, James L.M., Zhao, Shuang, Wang, Tianyi, Chang, Lawrence, Harris, Andrew, Pawarode, Attaphol, Kitko, Carrie, Magenau, John M., Yanik, Gregory A., Couriel, Daniel R., Goldstein, Steven, Connelly, James, Reddy, Pavan, Paczesny, Sophie, Choi, Sung Won
Publicado em 2014

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

Por Song, Yeohan, Magenau, John, Li, Yumeng, Braun, Thomas, Chang, Lawrence, Bixby, Dale, Hanauer, David A., Chughtai, Komal A., Gatza, Erin, Couriel, Daniel, Goldstein, Steven, Pawarode, Attaphol, Reddy, Pavan, Riwes, Mary, Connelly, James, Harris, Andrew, Kitko, Carrie, Levine, John, Yanik, Greg, Parkin, Brian, Choi, Sung Won
Publicado no Bone Marrow Transplant (2015)

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic...

Por Choi, Sung Won, Braun, Thomas, Chang, Lawrence, Ferrara, James L.M., Pawarode, Attaphol, Magenau, John M., Hou, Guoqing, Beumer, Jan H., Levine, John E., Goldstein, Steve, Couriel, Daniel R., Stockerl-Goldstein, Keith, Krijanovski, Oleg I., Kitko, Carrie, Yanik, Gregory A., Lehmann, Michael H., Tawara, Isao, Sun, Yaping, Paczesny, Sophie, Mapara, Markus Y., Dinarello, Charles A., DiPersio, John F., Reddy, Pavan
Publicado em 2013